Literature DB >> 25370038

Germline variants in POLE are associated with early onset mismatch repair deficient colorectal cancer.

Fadwa A Elsayed1, C Marleen Kets2, Dina Ruano1, Brendy van den Akker1, Arjen R Mensenkamp2, Melanie Schrumpf1, Maartje Nielsen3, Juul T Wijnen4, Carli M Tops3, Marjolijn J Ligtenberg5, Hans F A Vasen6, Frederik J Hes3, Hans Morreau1, Tom van Wezel1.   

Abstract

Germline variants affecting the exonuclease domains of POLE and POLD1 predispose to multiple colorectal adenomas and/or colorectal cancer (CRC). The aim of this study was to estimate the prevalence of previously described heterozygous germline variants POLE c.1270C>G, p.(Leu424Val) and POLD1 c.1433G>A, p.(Ser478Asn) in a Dutch series of unexplained familial, early onset CRC and polyposis index cases. We examined 1188 familial CRC and polyposis index patients for POLE p.(Leu424Val) and POLD1 p.(Ser478Asn) variants using competitive allele-specific PCR. In addition, protein expression of the POLE and DNA mismatch repair genes was studied by immunohistochemistry in tumours from POLE carriers. Somatic mutations were screened using semiconductor sequencing. We detected three index patients (0.25%) with a POLE p.(Leu424Val) variant. In one patient, the variant was found to be de-novo. Tumours from three patients from two families were microsatellite instable, and immunohistochemistry showed MSH6/MSH2 deficiency suggestive of Lynch syndrome. Somatic mutations but no germline MSH6 and MSH2 variants were subsequently found, and one tumour displayed a hypermutator phenotype. None of the 1188 patients carried the POLD1 p.(Ser478Asn) variant. POLE germline variant carriers are also associated with a microsatellite instable CRC. POLE DNA analysis now seems warranted in microsatellite instable CRC, especially in the absence of a causative DNA mismatch repair gene germline variant.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25370038      PMCID: PMC4351893          DOI: 10.1038/ejhg.2014.242

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  25 in total

Review 1.  DNA polymerases that propagate the eukaryotic DNA replication fork.

Authors:  Parie Garg; Peter M J Burgers
Journal:  Crit Rev Biochem Mol Biol       Date:  2005 Mar-Apr       Impact factor: 8.250

2.  Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer.

Authors:  Tsun Leung Chan; Siu Tsan Yuen; Chi Kwan Kong; Yee Wai Chan; Annie S Y Chan; Wai Fu Ng; Wai Yin Tsui; Michelle W S Lo; Wing Yip Tam; Vivian S W Li; Suet Yi Leung
Journal:  Nat Genet       Date:  2006-09-03       Impact factor: 38.330

Review 3.  The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases.

Authors:  Scott D McCulloch; Thomas A Kunkel
Journal:  Cell Res       Date:  2008-01       Impact factor: 25.617

4.  Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors.

Authors:  Arjen R Mensenkamp; Ingrid P Vogelaar; Wendy A G van Zelst-Stams; Monique Goossens; Hicham Ouchene; Sandra J B Hendriks-Cornelissen; Michael P Kwint; Nicoline Hoogerbrugge; Iris D Nagtegaal; Marjolijn J L Ligtenberg
Journal:  Gastroenterology       Date:  2013-12-10       Impact factor: 22.682

5.  Base selection, proofreading, and mismatch repair during DNA replication in Escherichia coli.

Authors:  R M Schaaper
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

Review 6.  DNA replication fidelity and cancer.

Authors:  Bradley D Preston; Tina M Albertson; Alan J Herr
Journal:  Semin Cancer Biol       Date:  2010-10-15       Impact factor: 15.707

7.  The burden of faulty proofreading in colon cancer.

Authors:  Somasekar Seshagiri
Journal:  Nat Genet       Date:  2013-02       Impact factor: 38.330

8.  Mutation at the polymerase active site of mouse DNA polymerase delta increases genomic instability and accelerates tumorigenesis.

Authors:  Ranga N Venkatesan; Piper M Treuting; Evan D Fuller; Robert E Goldsby; Thomas H Norwood; Ted A Gooley; Warren C Ladiges; Bradley D Preston; Lawrence A Loeb
Journal:  Mol Cell Biol       Date:  2007-09-04       Impact factor: 4.272

9.  Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR.

Authors:  Ronald van Eijk; Jappe Licht; Melanie Schrumpf; Mehrdad Talebian Yazdi; Dina Ruano; Giusi I Forte; Petra M Nederlof; Maud Veselic; Klaus F Rabe; Jouke T Annema; Vincent Smit; Hans Morreau; Tom van Wezel
Journal:  PLoS One       Date:  2011-03-08       Impact factor: 3.240

10.  Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas.

Authors:  Claire Palles; Jean-Baptiste Cazier; Kimberley M Howarth; Enric Domingo; Angela M Jones; Peter Broderick; Zoe Kemp; Sarah L Spain; Estrella Guarino; Estrella Guarino Almeida; Israel Salguero; Amy Sherborne; Daniel Chubb; Luis G Carvajal-Carmona; Yusanne Ma; Kulvinder Kaur; Sara Dobbins; Ella Barclay; Maggie Gorman; Lynn Martin; Michal B Kovac; Sean Humphray; Anneke Lucassen; Christopher C Holmes; David Bentley; Peter Donnelly; Jenny Taylor; Christos Petridis; Rebecca Roylance; Elinor J Sawyer; David J Kerr; Susan Clark; Jonathan Grimes; Stephen E Kearsey; Huw J W Thomas; Gilean McVean; Richard S Houlston; Ian Tomlinson
Journal:  Nat Genet       Date:  2012-12-23       Impact factor: 38.330

View more
  51 in total

1.  DNA mismatch repair protein deficient non-neoplastic colonic crypts: a novel indicator of Lynch syndrome.

Authors:  Rish K Pai; Beth Dudley; Eve Karloski; Randall E Brand; Neil O'Callaghan; Christophe Rosty; Daniel D Buchanan; Mark A Jenkins; Stephen N Thibodeau; Amy J French; Noralane M Lindor; Reetesh K Pai
Journal:  Mod Pathol       Date:  2018-06-08       Impact factor: 7.842

2.  Targeted next generation sequencing screening of Lynch syndrome in Tunisian population.

Authors:  Rihab Ben Sghaier; Anne Maria Lucia Jansen; Ahlem Bdioui; Tom Van Wezel; Mehdi Ksiaa; Lamia Elgolli; Leila Ben Fatma; Slim Ben Ahmed; Mohamed Msaddak Azzouz; Olfa Hellara; Amine Elghali; Fathi Darbel; Karim Skandrani; Moncef Mokkni; Ameni Gdissa; Rached Ltaief; Ali Saad; Fahmi Hmila; Moez Gribaa; Hans Morreau
Journal:  Fam Cancer       Date:  2019-07       Impact factor: 2.375

Review 3.  Clinical management of hereditary colorectal cancer syndromes.

Authors:  Hans F A Vasen; Ian Tomlinson; Antoni Castells
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-01-13       Impact factor: 46.802

Review 4.  Eukaryotic Mismatch Repair in Relation to DNA Replication.

Authors:  Thomas A Kunkel; Dorothy A Erie
Journal:  Annu Rev Genet       Date:  2015       Impact factor: 16.830

5.  Immunohistochemical null-phenotype for mismatch repair proteins in colonic carcinoma associated with concurrent MLH1 hypermethylation and MSH2 somatic mutations.

Authors:  Tao Wang; Zsofia K Stadler; Liying Zhang; Martin R Weiser; Olca Basturk; Jaclyn F Hechtman; Efsevia Vakiani; Lenard B Saltz; David S Klimstra; Jinru Shia
Journal:  Fam Cancer       Date:  2018-04       Impact factor: 2.375

6.  Polymerase-mediated ultramutagenesis in mice produces diverse cancers with high mutational load.

Authors:  Hao-Dong Li; Ileana Cuevas; Musi Zhang; Changzheng Lu; Md Maksudul Alam; Yang-Xin Fu; M James You; Esra A Akbay; He Zhang; Diego H Castrillon
Journal:  J Clin Invest       Date:  2018-08-20       Impact factor: 14.808

7.  Development of an MSI-positive colon tumor with aberrant DNA methylation in a PPAP patient.

Authors:  Kiyoshi Yamaguchi; Eigo Shimizu; Rui Yamaguchi; Seiya Imoto; Mitsuhiro Komura; Seira Hatakeyama; Rei Noguchi; Kiyoko Takane; Tsuneo Ikenoue; Yoshimasa Gohda; Hideaki Yano; Satoru Miyano; Yoichi Furukawa
Journal:  J Hum Genet       Date:  2019-05-14       Impact factor: 3.172

8.  Implication of DNA repair genes in Lynch-like syndrome.

Authors:  Rosa M Xicola; Julia R Clark; Timothy Carroll; Jurgis Alvikas; Priti Marwaha; Maureen R Regan; Francesc Lopez-Giraldez; Jungmin Choi; Rajyasree Emmadi; Victoria Alagiozian-Angelova; Sonia S Kupfer; Nathan A Ellis; Xavier Llor
Journal:  Fam Cancer       Date:  2019-07       Impact factor: 2.375

9.  Regulation of therapeutic resistance in cancers by receptor tyrosine kinases.

Authors:  Mei-Kuang Chen; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2016-03-15       Impact factor: 6.166

10.  MSH6 immunohistochemical heterogeneity in colorectal cancer: comparative sequencing from different tumor areas.

Authors:  Wei Chen; Rachel Pearlman; Heather Hampel; Colin C Pritchard; Michael Markow; Christina Arnold; Deborah Knight; Wendy L Frankel
Journal:  Hum Pathol       Date:  2019-11-27       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.